Global Automated External Defibrillator Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022-2027)

Market Overview

The global automated external defibrillator market was valued at USD 717.52 million in 2021, and it is projected to register a CAGR of 9.4% during the forecast period. Automated external defibrillators are life-saving devices that help in the correction of cardiac rhythm. The major factors driving the growth of the automated electronic defibrillator market include the growing prevalence of cardiac diseases, the rising geriatric population, and technological advancements in the field, supported by increasing investments from market players.

Since the start of the pandemic, COVID-19 has affected the global economy in three ways, by directly affecting production and demand, by creating a disruption in the supply chain, and financial impact on firms and financial markets due to strict lockdowns in most countries. Delays in the delivery of products and services have been seen due to countries' newer packaging protocols and lockdown measures. All these factors negatively impacted the manufacturing and supply chain of the defibrillators market. However, it is balanced by the increase in demand due to the surge in cardiovascular patients across all the regions as automated external is an effective intervention for cardiac arrest.

The burden of cardiac diseases is rising with the prevailing sedentary lifestyle in the population and the growing geriatric population around the world. For instance, the Journal of Cardiovascular Development and Disease article titled ‘’Cardiovascular Risks Associated with Gender, and Aging’’, published in April 2019, reported that the aging and elderly populations are particularly susceptible to cardiovascular diseases.

Additionally, it also reported that risk factors closely associated with advanced age, such as frailty, obesity, and diabetes, have been shown to compound risks of cardiovascular disease. Such studies demonstrate that the chances of cardiovascular diseases increase with age.

Furthermore, according to the Australian Government, Australia Institute of Health and Welfare article titled ‘‘Heart, stroke and vascular disease—Australian facts’’, updated in September 2021, reported that in 2019, cardiovascular diseases were the underlying cause of death in Australia and accounted for 42,300 deaths, which are nearly 25% of all deaths in Australia. Such a high burden of deaths generates a need for automated external defibrillators, thus driving the market's growth.

Moreover, the technological advancement in the field and the launch of new products by the market players boost the market's growth. For instance, in July 2020, ZOLL Medical Corporation (Asahi Kasei Group company) launched its new remote view technology on the X Series monitor/defibrillator developed for EMS agencies.

Thus, the automated external defibrillators market is expected to show lucrative growth over the forecast period. However, factors such as stringent regulations and lack of awareness and early corrective measures about Sudden Cardiac Arrest (SAC) may hinder the growth of the studied market over the forecast period.

Scope of the Report

An automated external defibrillator (AED) is a lightweight, portable device that delivers an electric shock through the chest to the heart. The shock can potentially stop an irregular heartbeat and allow a normal rhythm to resume following a sudden cardiac arrest (SCA). The global automated external defibrillator market is segmented by analysis type (semi-automated external defibrillators and fully automated external defibrillators), end user (hospitals/clinics, home care, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Rising Prevalence of Cardiac Diseases to Drive the Market

The rising prevalence of cardiac diseases across different age groups due to stressful work conditions, sedentary lifestyle, growing consumption of tobacco and alcohol, and substance abuse is expected to drive the growth of the automated external defibrillator market over the forecast period.

According to the International Journal of Stroke article titled ‘‘Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge’’, published in January 2020, the worldwide prevalence of atrial fibrillation was 37,574 million cases (0.51% of worldwide population), which increased by 33% during the last 20 years. It also reported that future projections suggest that the absolute atrial fibrillation burden may increase by more than 60% in 2050. Such a growing burden of arrhythmia creates demand for the automated external defibrillator and is expected to drive the growth of the studied market over the forecast period.

As per an article published in the Australia Institute of Health and Welfare titled ‘’Heart, stroke and vascular disease—Australian facts’’, updated in September 2021, during 2018-2019, there were 5,91,000 hospitalizations with cardiovascular diseases as principal diagnosis happened in Australia. Such a high number of hospitalization due to cardiovascular diseases generates a need for devices for correct cardiac rhythm. Thus, it is expected to drive the growth of the market.

Furthermore, the increasing number of deaths due to cardiac diseases is also boosting the market's growth. For instance, the World Health Organization (WHO)’s article titled ‘’Cardiovascular diseases (CVDs)’’, published in June 2021, reported that cardiovascular diseases are the leading cause of death globally. Additionally, it reported that an estimated 17.9 million people died from CVDs in 2019, which represented 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Such a high number of deaths due to it creates demand for the devices that help in cardiac rhythm corrections, driving the market's growth.

Also, the Journal of Cardiovascular Development and Disease article titled ‘‘Cardiovascular Risks Associated with Gender and Aging’’, published in April 2019, reported that in the American Heart Association (AHA) 2019 Heart Disease and Stroke Statistical Update, the incidence of cardiovascular diseases from age 60–79 years was 77.2% in males and 78.2% in females. Furthermore, the incidence of CVD in adults above 80 years of age was 89.3% in males and 91.8% in females. Such a high prevalence of cardiac disease in older age is driving the market's growth. Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period.

To understand key trends, Download Sample Report